Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study.

Details

Ressource 1Download: BIB_35348378B2FA.P001.pdf (540.69 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_35348378B2FA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study.
Journal
Orphanet Journal of Rare Diseases
Author(s)
Salort-Campana E., Nguyen K., Bernard R., Jouve E., Solé G., Nadaj-Pakleza A., Niederhauser J., Charles E., Ollagnon E., Bouhour F., Sacconi S., Echaniz-Laguna A., Desnuelle C., Tranchant C., Vial C., Magdinier F., Bartoli M., Arne-Bes M.C., Ferrer X., Kuntzer T., Levy N., Pouget J., Attarian S.
ISSN
1750-1172 (Electronic)
ISSN-L
1750-1172
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
10
Number
1
Pages
2
Language
english
Notes
Publication types: ARTICLE
Abstract
BackgroundFacioscapulohumeral muscular dystrophy type 1(FSHD1) is an autosomal dominant disorder associated with the contraction of D4Z4 less than 11 repeat units (RUs) on chromosome 4q35. Penetrance in the range of the largest alleles is poorly known. Our objective was to study the penetrance of FSHD1 in patients carrying alleles ranging between 6 to10 RUs and to evaluate the influence of sex, age, and several environmental factors on clinical expression of the disease. Methods A cross-sectional multicenter study was conducted in six French and one Swiss neuromuscular centers. 65 FSHD1 affected patients carrying a 4qA allele of 6¿10 RUs were identified as index cases (IC) and their 119 at-risk relatives were included. The age of onset was recorded for IC only. Medical history, neurological examination and manual muscle testing were performed for each subject. Genetic testing determined the allele size (number of RUs) and the 4qA/4qB allelic variant. The clinical status of relatives was established blindly to their genetic testing results. The main outcome was the penetrance defined as the ratio between the number of clinically affected carriers and the total number of carriers. Results Among the relatives, 59 carried the D4Z4 contraction. At the clinical level, 34 relatives carriers were clinically affected and 25 unaffected. Therefore, the calculated penetrance was 57% in the range of 6¿10 RUs. Penetrance was estimated at 62% in the range of 6¿8 RUs, and at 47% in the range of 9¿10 RUs. Moreover, penetrance was lower in women than men. There was no effect of drugs, anesthesia, surgery or traumatisms on the penetrance. Conclusions Penetrance of FSHD1 is low for largest alleles in the range of 9¿10 RUs, and lower in women than men. This is of crucial importance for genetic counseling and clinical management of patients and families.
Pubmed
Web of science
Open Access
Yes
Create date
10/04/2015 18:28
Last modification date
20/08/2019 13:22
Usage data